Are These Companies Heading To Zero? Vedanta Resources plc, Lonmin Plc, African Potash Ltd, KAZ Minerals PLC & Jubilee Platinum PLC

Are Vedanta Resources plc (LON: VED), Lonmin Plc (LON: LMI), African Potash Ltd (LON: AFPO), KAZ Minerals PLC (LON: KAZ) and Jubilee Platinum PLC (LON: JLP) going out of business?

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

The commodity rout has sent shockwaves across the mining sector. Unfortunately, it’s now becoming apparent that many miners won’t be able to survive the downturn.

Will KAZ Minerals (LSE: KAZ), Vedanta Resources (LSE: VED), Jubilee Platinum (LSE: JLP), Lonmin (LSE: LMI) and African Potash (LSE: AFPO) be able to survive?

Loss-making production  

At the end of August, Kaz’s shares jumped by a fifth after announcing the results, which beat expectations.

Since the release of these results, however, a lot has changed. Alongside the half-year results, Kaz revealed that its full-year copper production cost guidance would be in the region of 260 to 280 cents per pound. But at the end of August, the price of copper crashed to 220 cents per pound, indicating that Kaz is losing money on every pound of copper produced. 

Essential merger

According to City, it’s essential that Vedanta completes its merger with Cairn India for the company to be able to withstand the weakness in global commodity prices.

It’s so important that Vedanta completes its merger with Cairn India that credit ratings agency, Standard & Poor’s has placed Vedanta on credit watch, ahead of a possible downgrade if the merger doesn’t go ahead. 

Vedanta’s management expects the deal to complete during the fourth quarter of 2015. So, investors will have to wait for further clarity on Vedanta’s outlook. Still, management has stated that the company’s 9.4% is here to stay for the time being

Long way to go

Jubilee Platinum has surged 160% in the last six months weeks but has fallen by more than 30% since the beginning of August. News regarding asset sales, financing deals and the company’s pipeline of projects have all boosted the investment case for Jubilee, although the company has a long way to go before it can stand on its own two feet. 

Moreover, it is unclear how the 30% fall in the price of platinum over the past six months will affect the company.

And as the price of platinum slumps, Lonmin’s financial performance is only going for bad to worse. Lonmin is expected to post as pre-tax loss of £90m this year followed by a further £20m loss next year. Further, management is struggling to refinance the group’s debt.

Lonmin may look like a bargain, as it currently trades at a price to book value of just 0.06, but it should be avoided.

Difficult to call

It’s difficult to call African Potash’s outlook. With a market cap. of only £21.5m the company is off the radar of most investors but that hasn’t stopped the stock rising more than 600% over the past three months. 

Most of these gains have been driven by the news that African Potash has inked several supply deals for the supply of fertiliser. At the end of last week the company announced that it had agreed on a price of $500 per metric tonne in respect of 50,000 MT fertiliser product to be sold under a supply agreement signed at the end of August. Also, a trade finance facility of up to $50m is currently being arranged for African Potash. 

So unlike Vedanta, Lonmin and Kaz, African Potash looks to have a bright future ahead of it, as management push through the company’s business plan. 

Rupert Hargreaves has no position in any shares mentioned. The Motley Fool UK has no position in any of the shares mentioned. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Middle-aged white man pulling an aggrieved face while looking at a screen
Market Movers

Down 7%! Why on earth are Imperial Brands shares plummeting today?

Imperial Brands shares are in freefall after a negative reception to fresh trading news. Is the party finally over for…

Read more »

Rear View Of Woman Holding Man Hand during travel in cappadocia
Investing Articles

With a P/E under 7, this value stock looks far too cheap at 101p

This writer reckons value stock Hostelworld (LSE:HSW) looks dirt-cheap as it gets dividends flowing again and builds a social travel…

Read more »

Thoughtful man using his phone while riding on a train and looking through the window
Investing For Beginners

Down 30% in 6 months, I think there’s a big catch to this insanely cheap stock

Jon Smith talks through why careful research is needed when trying to assess if a cheap stock is worth buying…

Read more »

Investing Articles

£5,000 invested in National Grid shares 5 years ago is now worth…

Andrew Mackie takes a closer look at National Grid shares and why short-term market weakness could be missing a powerful…

Read more »

DIVIDEND YIELD text written on a notebook with chart
Investing Articles

How big does an ISA need to be to aim for a £1,500 monthly second income?

Harvey Jones shows how building a balanced portfolio of FTSE 100 dividend stocks can produce a high-and-rising second income in…

Read more »

Person holding magnifying glass over important document, reading the small print
Investing Articles

£20,000 invested in BP shares 1 year ago is now worth…

BP shares have rocketed in the past 12 months, yet analysts think the real growth story is only just beginning,…

Read more »

A pastel colored growing graph with rising rocket.
Investing Articles

A 6.8% forecast yield! 1 often-overlooked FTSE 100 income stock to buy today?

This income stock offers a high forecast yield and strengthening momentum, yet many investors overlook it — creating a rare…

Read more »

GSK scientist holding lab syringe
Investing Articles

GSK’s share price is under £22, but with a ‘fair value’ much higher, is it time for me to buy more right now? 

GSK’s share price rose over the last year, but a huge gap remains between its price and fair value —…

Read more »